肌少症能否预测急性胆囊炎所致脓毒症的不良预后?
本研究为回顾性单中心观察性研究,纳入2016年1月至2021年12月急诊就诊的成人急性胆囊炎所致脓毒症患者374例,通过L3水平双侧腰大肌面积计算经身高校正的腰大肌指数(PMI),按性别取PMI下四分位数定义肌少症(男性<423 mm²/m²,女性<269 mm²/m²)。肌少症组94例,非肌少症组280例。肌少症与ICU入住(OR 1.98;95%CI 1.05-3.76)及院内死亡(OR 6.40;95%CI 1.13-36.09)显著相关,肌少症组住院时间中位数11.5天,显著长于非肌少症组的8天。作者结论认为肌少症与ICU入住、住院时间及院内死亡显著相关。
要点
- 在急性胆囊炎所致脓毒症成人患者中,肌少症(男性PMI<423 mm²/m²、女性<269 mm²/m²)与院内死亡相关(OR 6.40;95%CI 1.13-36.09)。
- 肌少症与ICU入住显著相关(OR 1.98;95%CI 1.05-3.76)。
- 肌少症组住院时间中位数11.5天,非肌少症组中位数8天,肌少症组显著更长。
- 肌少症定义采用L3水平双侧腰大肌面积计算的PMI,按性别取本队列下四分位数作为切点。
适用人群与场景
- 2016年1月至2021年12月急诊就诊的成人急性胆囊炎所致脓毒症患者。
诊断标准与关键阈值
- 肌少症定义:根据性别取PMI下四分位数作为切点,男性PMI<423 mm²/m²,女性PMI<269 mm²/m²。
- PMI计算方法:测量L3水平双侧腰大肌面积,经患者身高校正计算腰大肌指数(PMI)。
研究设计与关键结果
- 研究类型:回顾性单中心观察性研究,共纳入374例成人急性胆囊炎所致脓毒症患者。
- 分组:肌少症组94例,非肌少症组280例。
- 主要终点院内死亡:肌少症与非肌少症相比OR 6.40(95%CI 1.13-36.09)。
- 次要终点ICU入住:肌少症与非肌少症相比OR 1.98(95%CI 1.05-3.76)。
- 次要终点住院时间:肌少症组中位数11.5天,非肌少症组中位数8天,肌少症组显著更长。
证据类型、等级与局限
- 证据类型:回顾性单中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在急性胆囊炎所致脓毒症患者中,肌少症与ICU入住、住院时间及院内死亡显著相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM OF THE STUDY: As sepsis is a life-threatening disease, it is important to predict the prognosis in the early stages to establish treatment plans. This study aimed to investigate the association between sarcopenia, determined by the psoas muscle area, and the prognosis of sepsis due to acute cholecystitis.
METHODS: This retrospective single-center observational study included adult patients with sepsis due to acute cholecystitis who visited the emergency department between January 2016 and December 2021. The area of both sides of the psoas muscle at the L3 level was measured, and the psoas muscle index (PMI) corrected by the patient's height was calculated. Sarcopenia was determined based on PMI. The primary outcome was in-hospital mortality, and secondary outcomes were intensive care unit (ICU) admission, length of hospital stay (LOS), and 14-day mortality.
RESULTS: A total of 374 patients were included in this study. In this cohort, the lower quartile of PMI according to gender was set as the cut-off value to define sarcopenia. Sarcopenia was defined as PMI < 423 mm2/m2 for males and < 269 mm2/m2 for females. There were 94 patients in the sarcopenic group and 280 in the non-sarcopenic group. There was a significant association between sarcopenia and ICU admission (odds ratio [OR], 1.98; 95% confidence interval [CI], 1.05-3.76), and there was also a significant association between sarcopenia and in-hospital mortality (OR, 6.40; 95%CI, 1.13-36.09). Additionally, the median LOS in the sarcopenic group (11.5 (Cruz-Jentoft et al., 2010; Kawaguchi et al., 2019; Kim et al., 2017; Ritz et al., 2021; Cox et al., 2021; Lee et al., 2018; Okada et al., 2021; Prashanthi et al., n.d.; Amini et al., 2015; Fearon et al., 2011) days) was significantly longer than the median (8 (Rosenberg, 1989, 1997; Cruz-Jentoft et al., 2010; Kawaguchi et al., 2019; Kim et al., 2017; Ritz et al., 2021) days) in the non-sarcopenic group.
CONCLUSIONS: In patients with sepsis due to acute cholecystitis, sarcopenia was significantly associated with ICU admission, LOS, and in-hospital mortality.
参考来源
- Kim HB, Chun SY, Kim GW, et al. Can sarcopenia predict poor prognosis of sepsis due to acute cholecystitis? Am J Emerg Med. 2023. PMID: 37619445. doi:10.1016/j.ajem.2023.08.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。